Auto-Injectors Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-02-10　·　152 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 8,724.60 Mn
2033 年預估規模: USD 27,660.0 Mn
年複合成長率 CAGR: 18%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Auto-Injectors Market, By Product Type (Prefilled Auto-injectors, Fillable Auto-injectors), By Disease Indication (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others (Diabetes, Psoriasis, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Auto- injector is a medical device which can deliver dose of medications. Auto injectors are easy to use and self-administration by patients is possible. Auto-injectors are disposable and there is a tremendous growth in the development of reusable auto-injectors with multiple dosing. Auto-injectors come under injectable drug delivery which is considered as the most effective route of administration for the effective delivery of drugs to the targeted site, which enhances the patient’s compliance to the drug. The Injectable delivery enhances the rapid absorption of drug from various sites such as subcutaneous, intravenous, and intramuscular. The injectable delivery increases the bioavailability of the drug at the systemic circulation, which offers availability of drug at intended site of action. Epinephrine auto-injector is a type of auto-injector widely used for people at risk of anaphylaxis. Auto-injectors enclose prefilled syringes or cartridges which are driven by a spring system. Auto-injectors are often used in the military to protect personnel from chemical warfare agents. Market Dynamics Adoption of inorganic growth strategies such as product launch by key market players is expected to drive the global auto-injectors market over the forecast period. For instance, in April 2020, Teva Pharmaceutical Industries Ltd., a pharmaceutical company, announced that they had launched auto-injector for AJOVY, which is indicated for the preventive treatment of migraine in adults. This new auto-injector has several features such as easy handling including a button-free, push-down mechanism, audible cues that signal progress of administration, and a window that displays when the dose has been delivered. Key features of the study • This report provides an in-depth analysis of the global auto-injectors market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global auto-injectors market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Becton, Dickinson and Company, Sanofi S.A., Takeda Pharmaceutical Company Limited, Xeris Biopharma Holdings Inc., BlackHagen Design, GSK plc., Genentech, Inc., AstraZeneca, Owen Mumford Ltd., Stevanato Group, Jabil Inc., Pfizer, Inc., Mylan N.V., Novartis AG, Bayer AG, Janssen Pharmaceuticals, Inc., Antares Pharma, Eli Lilly and Company, Amgen Inc., Rafa Laboratories Ltd., Halozyme, Inc., Biogen, and Teva Pharmaceutical Industries Ltd. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global auto-injectors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global auto-injectors market Market Segmentation • By Product Type o Prefilled Auto-injectors o Fillable Auto-injectors • By Disease Indication o Anaphylaxis o Multiple Sclerosis o Rheumatoid Arthritis o Others (Diabetes, Psoriasis, etc.) • By Distribution Channel o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • By Region o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players o Becton, Dickinson and Company o Sanofi S.A. o Takeda Pharmaceutical Company Limited o Xeris Biopharma Holdings Inc. o BlackHagen Design o GSK plc. o Genentech, Inc. o AstraZeneca o Owen Mumford Ltd. o Stevanato Group o Jabil Inc. o Pfizer, Inc. o Mylan N.V. o Novartis AG o Bayer AG o Janssen Pharmaceuticals, Inc. o Antares Pharma o Eli Lilly and Company o Amgen Inc. o Rafa Laboratories Ltd. o Halozyme, Inc. o Biogen o Teva Pharmaceutical Industries L

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Product Type  Market Snapshot, By Disease Indication  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Recent Developments o Acquisitions and Partnerships Scenario o Technology Overview o Regulatory Scenario o PEST Analysis 4. Global Auto-injectors Market, By Product Type, 2026 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Prefilled Auto-injectors  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Fillable Auto-injectors  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) 5. Global Auto-injectors Market, By Disease Indication, 2026 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Anaphylaxis  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Multiple Sclerosis  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Rheumatoid Arthritis  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Others (Diabetes, Psoriasis, etc.)  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) 6. Global Auto-injectors Market, By Distribution Channel, 2026 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Hospital Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Retail Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) o Online Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Mn) 7. Global Auto-injectors Market, By Region, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2026–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (USD Mn) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Becton, Dickinson and Company  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Sanofi S.A.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Takeda Pharmaceutical Company Limited  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Xeris Biopharma Holdings Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o BlackHagen Design  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o GSK plc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Genentech, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o AstraZeneca  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Owen Mumford Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Stevanato Group  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Jabil Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Pfizer, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Mylan N.V.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Novartis AG  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Bayer AG  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Janssen Pharmaceuticals, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Antares Pharma  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Eli Lilly and Company  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Amgen, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Rafa Laboratories Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Halozyme, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Biogen  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Teva Pharmaceutical Industries Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 9. Section o Research Methodology o About Us

提及公司

Becton, Dickinson and CompanySanofi S.A.Takeda Pharmaceutical Company LimitedXeris Biopharma Holdings Inc.BlackHagen DesignGSK plc.Genentech, Inc.AstraZenecaOwen Mumford Ltd.Stevanato GroupJabil Inc.Pfizer, Inc.Mylan N.V.Novartis AGBayer AGJanssen Pharmaceuticals, Inc.Antares PharmaEli Lilly and CompanyAmgen Inc.Rafa Laboratories Ltd.Halozyme, Inc.BiogenTeva Pharmaceutical Industries L

同分類最新報告（醫療器材）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們